PHARMACOLOGY HESI EXAM TEST BANK
2026/2027
Comprehensive Question Set with Verified Answers
HESI RN Pharmacology Examination | Aligned with 2026-2027 HESI Testing Standards
Nine Content Sections | 150 Questions | Detailed Evidence-Based Pharmacology Rationales
Total
Question Format Cognitive Levels Scenario Focus
Questions
75% scenario-based including
Multiple Choice (A-D), one 25% recall, 50% application,
150 NGN-style case studies, 25% direct
correct answer 25% analysis
recall
Directions: Each question in this comprehensive test bank presents a pharmacology problem aligned with the HESI
RN Pharmacology examination blueprint. Read the clinical scenario carefully, select the single best answer among
the four options, and then review the verified correct answer and the accompanying rationale. Every rationale
explains the mechanism of action, pharmacokinetic or pharmacodynamic principle, and clinical reasoning that
distinguishes the correct choice from the plausible distractors, mirroring the level of analysis expected on the actual
examination.
SECTION 1 - PHARMACOKINETICS AND PHARMACODYNAMICS
Questions 1-20 | ADME Processes | Receptor Theory | Therapeutic Index | Half-Life | Drug Interactions
Q1: A client with chronic angina pectoris is prescribed nitroglycerin. The nurse explains that sublingual
administration, rather than oral tablets, is used for acute episodes primarily because of which
pharmacokinetic principle?
A. Oral nitroglycerin is completely destroyed by gastric hydrochloric acid before absorption can occur.
B. Sublingual administration increases the protein binding of nitroglycerin and prolongs its duration of
action.
C. Sublingual administration completely bypasses the hepatic first-pass effect, allowing the full
dose to reach systemic circulation. [CORRECT]
D. Sublingual administration increases the biotransformation of nitroglycerin into its active metabolite.
Correct Answer: C
Rationale: Nitroglycerin undergoes extensive first-pass hepatic metabolism when swallowed, deactivating the
majority of the oral dose before it reaches systemic circulation. The sublingual route allows direct absorption
through the oral mucosa into the superior vena cava, bypassing the portal circulation and the liver initially, which
produces rapid therapeutic blood levels within 1 to 3 minutes. Option B is incorrect because protein binding does
not differ meaningfully by route and sublingual doses act briefly, not longer. Option A is incorrect because oral
nitroglycerin is not destroyed by gastric acid; it is metabolized by the liver. Option D is incorrect because avoiding
first-pass metabolism decreases, not increases, biotransformation of the drug.
HESI RN Pharmacology Examination Test Bank 2026/2027 1
,Pharmacology HESI Exam Test Bank 2026/2027 - Comprehensive Question Set with Verified Answers
Q2: Which statement made by a nursing student correctly defines bioavailability?
A. The amount of drug that binds to plasma albumin after absorption from the gastrointestinal tract.
B. The fraction of an administered dose of drug that reaches systemic circulation in an
unchanged and active form. [CORRECT]
C. The rate at which an administered drug is metabolized by hepatic cytochrome enzymes.
D. The concentration of drug required to produce 50 percent of the maximum therapeutic effect.
Correct Answer: B
Rationale: Bioavailability is the proportion of an administered dose that reaches systemic circulation intact and
available for pharmacologic action; intravenous dosing provides 100 percent bioavailability by definition. Option A
describes plasma protein binding, a distribution characteristic rather than bioavailability. Option C describes the
metabolic clearance rate, which influences bioavailability but does not define it. Option D describes EC50, a
pharmacodynamic potency measure unrelated to the definition of bioavailability.
Q3: A client stabilized on warfarin is newly prescribed sulfamethoxazole-trimethoprim, a highly
protein-bound antibiotic. The nurse monitors this client closely for bleeding because the antibiotic causes
which effect?
A. Competitive antagonism of warfarin at vitamin K receptor sites, which neutralizes anticoagulation.
B. Acceleration of warfarin hepatic metabolism, which lowers the INR and decreases anticoagulant
effect.
C. Displacement of warfarin from plasma protein binding sites, which increases free warfarin
levels and anticoagulant effect. [CORRECT]
D. Increased biliary excretion of warfarin, which requires an increase in the warfarin dose.
Correct Answer: C
Rationale: Warfarin is approximately 99 percent protein bound. When another highly protein-bound drug such as
sulfamethoxazole is added, the two agents compete for albumin binding sites, displacing warfarin and transiently
raising the concentration of free, pharmacologically active drug, which substantially increases bleeding risk. Option
B describes enzyme induction, which would lower INR, but this interaction is primarily displacement. Option A is
incorrect because warfarin inhibits vitamin K epoxide reductase intracellularly and is not antagonized at receptor
sites by sulfamethoxazole. Option D is incorrect because the interaction does not involve enhanced biliary
elimination.
HESI RN Pharmacology Examination Test Bank 2026/2027 2
,Pharmacology HESI Exam Test Bank 2026/2027 - Comprehensive Question Set with Verified Answers
Q4: A nurse is caring for a client with bacterial meningitis. When selecting an antibiotic regimen, the
health care provider chooses ceftriaxone specifically because it possesses which distribution
characteristic?
A. It binds exclusively to leukocytes, which transport the drug into the central nervous system.
B. It is almost entirely ionized in plasma, which promotes active transport across the blood-brain barrier.
C. It is highly lipid soluble and able to cross the inflamed blood-brain barrier into cerebrospinal
fluid. [CORRECT]
D. It has a very large volume of distribution, which guarantees delivery to all body tissues including brain
tissue.
Correct Answer: C
Rationale: The blood-brain barrier permits passage of only highly lipid-soluble, low-molecular-weight, or actively
transported agents. In meningitis, inflammation increases barrier permeability, and drugs such as ceftriaxone can
then achieve therapeutic cerebrospinal fluid concentrations. Option B is incorrect because ionized, water-soluble
drugs cross lipid membranes poorly and do not traverse the intact barrier by passive diffusion. Option A is false;
antibiotics are not ferried into the central nervous system by leukocyte binding. Option D confuses volume of
distribution with barrier penetration, since a large volume of distribution does not guarantee intracranial drug
delivery.
Q5: A pregnant client at 28 weeks of gestation asks the nurse why her health care provider switched her
antihypertensive from lisinopril to labetalol. Which response by the nurse is most accurate?
A. ACE inhibitors are contraindicated in pregnancy because they greatly accelerate maternal hepatic
drug clearance.
B. ACE inhibitors increase maternal cardiac output so dramatically during pregnancy that they cause
placental abruption.
C. Labetalol is chosen because it has a larger molecular size that prevents any placental transfer of the
drug.
D. ACE inhibitors can cross the placenta and cause fetal renal damage, oligohydramnios, and
developmental injury, so they are avoided in pregnancy. [CORRECT]
Correct Answer: D
Rationale: Most drugs cross the placenta by passive diffusion, and ACE inhibitors taken during the second and
third trimesters are associated with fetal renal dysgenesis, oligohydramnios, fetal growth restriction, and neonatal
renal failure. Labetalol is a preferred, pregnancy-safe antihypertensive. Option B describes a non-existent
mechanism. Option C is incorrect because labetalol does cross the placenta; it is selected for its favorable fetal
safety profile, not because transfer is prevented. Option A is incorrect because altered maternal clearance is not the
reason ACE inhibitors are avoided.
HESI RN Pharmacology Examination Test Bank 2026/2027 3
, Pharmacology HESI Exam Test Bank 2026/2027 - Comprehensive Question Set with Verified Answers
Q6: A pharmacology instructor is reviewing drug metabolism with a group of nursing students. Which
statement by a student correctly distinguishes Phase II from Phase I biotransformation reactions?
A. Phase II reactions always precede Phase I reactions and must be completed before any drug can be
excreted.
B. Phase II reactions use the cytochrome P450 system to oxidize, reduce, or hydrolyze the parent drug
compound.
C. Phase II reactions convert lipid-soluble drugs into more lipid-soluble metabolites to promote tissue
storage.
D. Phase II reactions conjugate the drug or its metabolite with substances such as glucuronic acid
to form larger, usually inactive, water-soluble compounds. [CORRECT]
Correct Answer: D
Rationale: Phase II metabolism involves conjugation reactions, including glucuronidation, sulfation, acetylation,
and methylation, which attach polar groups to the drug to create water-soluble products suitable for renal or biliary
excretion. Option B correctly describes Phase I reactions, not Phase II. Option C is the opposite of the purpose of
metabolism, which generally increases water solubility. Option A is incorrect because Phase II reactions may occur
independently or after Phase I; Phase I does not always precede them.
Q7: A client who drinks large amounts of grapefruit juice daily is newly prescribed atorvastatin. The
nurse should teach the client that grapefruit juice creates which clinically significant interaction?
A. Induction of hepatic CYP2D6, which rapidly clears atorvastatin and eliminates its lipid-lowering
effect.
B. Inhibition of intestinal CYP3A4, which raises serum atorvastatin concentrations and increases
the risk of myopathy and rhabdomyolysis. [CORRECT]
C. Binding of atorvastatin in the intestinal lumen, which prevents absorption of the drug entirely.
D. Competition for renal tubular secretion, which causes atorvastatin to accumulate in the bladder.
Correct Answer: B
Rationale: Grapefruit juice contains furanocoumarins that irreversibly inhibit CYP3A4 within the intestinal wall.
For drugs such as atorvastatin that are CYP3A4 substrates, this inhibition increases systemic drug exposure and
raises the risk of dose-dependent adverse effects, most notably myalgias, myopathy, and life-threatening
rhabdomyolysis. Option A is incorrect because grapefruit juice inhibits rather than induces metabolism. Option C
describes chelation or adsorption interactions, which do not occur with grapefruit juice. Option D describes renal
transporter competition, which is not involved in this interaction.
HESI RN Pharmacology Examination Test Bank 2026/2027 4
2026/2027
Comprehensive Question Set with Verified Answers
HESI RN Pharmacology Examination | Aligned with 2026-2027 HESI Testing Standards
Nine Content Sections | 150 Questions | Detailed Evidence-Based Pharmacology Rationales
Total
Question Format Cognitive Levels Scenario Focus
Questions
75% scenario-based including
Multiple Choice (A-D), one 25% recall, 50% application,
150 NGN-style case studies, 25% direct
correct answer 25% analysis
recall
Directions: Each question in this comprehensive test bank presents a pharmacology problem aligned with the HESI
RN Pharmacology examination blueprint. Read the clinical scenario carefully, select the single best answer among
the four options, and then review the verified correct answer and the accompanying rationale. Every rationale
explains the mechanism of action, pharmacokinetic or pharmacodynamic principle, and clinical reasoning that
distinguishes the correct choice from the plausible distractors, mirroring the level of analysis expected on the actual
examination.
SECTION 1 - PHARMACOKINETICS AND PHARMACODYNAMICS
Questions 1-20 | ADME Processes | Receptor Theory | Therapeutic Index | Half-Life | Drug Interactions
Q1: A client with chronic angina pectoris is prescribed nitroglycerin. The nurse explains that sublingual
administration, rather than oral tablets, is used for acute episodes primarily because of which
pharmacokinetic principle?
A. Oral nitroglycerin is completely destroyed by gastric hydrochloric acid before absorption can occur.
B. Sublingual administration increases the protein binding of nitroglycerin and prolongs its duration of
action.
C. Sublingual administration completely bypasses the hepatic first-pass effect, allowing the full
dose to reach systemic circulation. [CORRECT]
D. Sublingual administration increases the biotransformation of nitroglycerin into its active metabolite.
Correct Answer: C
Rationale: Nitroglycerin undergoes extensive first-pass hepatic metabolism when swallowed, deactivating the
majority of the oral dose before it reaches systemic circulation. The sublingual route allows direct absorption
through the oral mucosa into the superior vena cava, bypassing the portal circulation and the liver initially, which
produces rapid therapeutic blood levels within 1 to 3 minutes. Option B is incorrect because protein binding does
not differ meaningfully by route and sublingual doses act briefly, not longer. Option A is incorrect because oral
nitroglycerin is not destroyed by gastric acid; it is metabolized by the liver. Option D is incorrect because avoiding
first-pass metabolism decreases, not increases, biotransformation of the drug.
HESI RN Pharmacology Examination Test Bank 2026/2027 1
,Pharmacology HESI Exam Test Bank 2026/2027 - Comprehensive Question Set with Verified Answers
Q2: Which statement made by a nursing student correctly defines bioavailability?
A. The amount of drug that binds to plasma albumin after absorption from the gastrointestinal tract.
B. The fraction of an administered dose of drug that reaches systemic circulation in an
unchanged and active form. [CORRECT]
C. The rate at which an administered drug is metabolized by hepatic cytochrome enzymes.
D. The concentration of drug required to produce 50 percent of the maximum therapeutic effect.
Correct Answer: B
Rationale: Bioavailability is the proportion of an administered dose that reaches systemic circulation intact and
available for pharmacologic action; intravenous dosing provides 100 percent bioavailability by definition. Option A
describes plasma protein binding, a distribution characteristic rather than bioavailability. Option C describes the
metabolic clearance rate, which influences bioavailability but does not define it. Option D describes EC50, a
pharmacodynamic potency measure unrelated to the definition of bioavailability.
Q3: A client stabilized on warfarin is newly prescribed sulfamethoxazole-trimethoprim, a highly
protein-bound antibiotic. The nurse monitors this client closely for bleeding because the antibiotic causes
which effect?
A. Competitive antagonism of warfarin at vitamin K receptor sites, which neutralizes anticoagulation.
B. Acceleration of warfarin hepatic metabolism, which lowers the INR and decreases anticoagulant
effect.
C. Displacement of warfarin from plasma protein binding sites, which increases free warfarin
levels and anticoagulant effect. [CORRECT]
D. Increased biliary excretion of warfarin, which requires an increase in the warfarin dose.
Correct Answer: C
Rationale: Warfarin is approximately 99 percent protein bound. When another highly protein-bound drug such as
sulfamethoxazole is added, the two agents compete for albumin binding sites, displacing warfarin and transiently
raising the concentration of free, pharmacologically active drug, which substantially increases bleeding risk. Option
B describes enzyme induction, which would lower INR, but this interaction is primarily displacement. Option A is
incorrect because warfarin inhibits vitamin K epoxide reductase intracellularly and is not antagonized at receptor
sites by sulfamethoxazole. Option D is incorrect because the interaction does not involve enhanced biliary
elimination.
HESI RN Pharmacology Examination Test Bank 2026/2027 2
,Pharmacology HESI Exam Test Bank 2026/2027 - Comprehensive Question Set with Verified Answers
Q4: A nurse is caring for a client with bacterial meningitis. When selecting an antibiotic regimen, the
health care provider chooses ceftriaxone specifically because it possesses which distribution
characteristic?
A. It binds exclusively to leukocytes, which transport the drug into the central nervous system.
B. It is almost entirely ionized in plasma, which promotes active transport across the blood-brain barrier.
C. It is highly lipid soluble and able to cross the inflamed blood-brain barrier into cerebrospinal
fluid. [CORRECT]
D. It has a very large volume of distribution, which guarantees delivery to all body tissues including brain
tissue.
Correct Answer: C
Rationale: The blood-brain barrier permits passage of only highly lipid-soluble, low-molecular-weight, or actively
transported agents. In meningitis, inflammation increases barrier permeability, and drugs such as ceftriaxone can
then achieve therapeutic cerebrospinal fluid concentrations. Option B is incorrect because ionized, water-soluble
drugs cross lipid membranes poorly and do not traverse the intact barrier by passive diffusion. Option A is false;
antibiotics are not ferried into the central nervous system by leukocyte binding. Option D confuses volume of
distribution with barrier penetration, since a large volume of distribution does not guarantee intracranial drug
delivery.
Q5: A pregnant client at 28 weeks of gestation asks the nurse why her health care provider switched her
antihypertensive from lisinopril to labetalol. Which response by the nurse is most accurate?
A. ACE inhibitors are contraindicated in pregnancy because they greatly accelerate maternal hepatic
drug clearance.
B. ACE inhibitors increase maternal cardiac output so dramatically during pregnancy that they cause
placental abruption.
C. Labetalol is chosen because it has a larger molecular size that prevents any placental transfer of the
drug.
D. ACE inhibitors can cross the placenta and cause fetal renal damage, oligohydramnios, and
developmental injury, so they are avoided in pregnancy. [CORRECT]
Correct Answer: D
Rationale: Most drugs cross the placenta by passive diffusion, and ACE inhibitors taken during the second and
third trimesters are associated with fetal renal dysgenesis, oligohydramnios, fetal growth restriction, and neonatal
renal failure. Labetalol is a preferred, pregnancy-safe antihypertensive. Option B describes a non-existent
mechanism. Option C is incorrect because labetalol does cross the placenta; it is selected for its favorable fetal
safety profile, not because transfer is prevented. Option A is incorrect because altered maternal clearance is not the
reason ACE inhibitors are avoided.
HESI RN Pharmacology Examination Test Bank 2026/2027 3
, Pharmacology HESI Exam Test Bank 2026/2027 - Comprehensive Question Set with Verified Answers
Q6: A pharmacology instructor is reviewing drug metabolism with a group of nursing students. Which
statement by a student correctly distinguishes Phase II from Phase I biotransformation reactions?
A. Phase II reactions always precede Phase I reactions and must be completed before any drug can be
excreted.
B. Phase II reactions use the cytochrome P450 system to oxidize, reduce, or hydrolyze the parent drug
compound.
C. Phase II reactions convert lipid-soluble drugs into more lipid-soluble metabolites to promote tissue
storage.
D. Phase II reactions conjugate the drug or its metabolite with substances such as glucuronic acid
to form larger, usually inactive, water-soluble compounds. [CORRECT]
Correct Answer: D
Rationale: Phase II metabolism involves conjugation reactions, including glucuronidation, sulfation, acetylation,
and methylation, which attach polar groups to the drug to create water-soluble products suitable for renal or biliary
excretion. Option B correctly describes Phase I reactions, not Phase II. Option C is the opposite of the purpose of
metabolism, which generally increases water solubility. Option A is incorrect because Phase II reactions may occur
independently or after Phase I; Phase I does not always precede them.
Q7: A client who drinks large amounts of grapefruit juice daily is newly prescribed atorvastatin. The
nurse should teach the client that grapefruit juice creates which clinically significant interaction?
A. Induction of hepatic CYP2D6, which rapidly clears atorvastatin and eliminates its lipid-lowering
effect.
B. Inhibition of intestinal CYP3A4, which raises serum atorvastatin concentrations and increases
the risk of myopathy and rhabdomyolysis. [CORRECT]
C. Binding of atorvastatin in the intestinal lumen, which prevents absorption of the drug entirely.
D. Competition for renal tubular secretion, which causes atorvastatin to accumulate in the bladder.
Correct Answer: B
Rationale: Grapefruit juice contains furanocoumarins that irreversibly inhibit CYP3A4 within the intestinal wall.
For drugs such as atorvastatin that are CYP3A4 substrates, this inhibition increases systemic drug exposure and
raises the risk of dose-dependent adverse effects, most notably myalgias, myopathy, and life-threatening
rhabdomyolysis. Option A is incorrect because grapefruit juice inhibits rather than induces metabolism. Option C
describes chelation or adsorption interactions, which do not occur with grapefruit juice. Option D describes renal
transporter competition, which is not involved in this interaction.
HESI RN Pharmacology Examination Test Bank 2026/2027 4
